{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:18:48Z","timestamp":1789672728202,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the project from Science and Technology of Ganzhou","award":["2023DXNS4747"],"award-info":[{"award-number":["2023DXNS4747"]}]},{"name":"the project from Science and Technology Department of Sichuan Province","award":["2022YFS0613"],"award-info":[{"award-number":["2022YFS0613"]}]},{"name":"the Sichuan Provincial Natural Science Foundation","award":["2024NSFSC1823"],"award-info":[{"award-number":["2024NSFSC1823"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15764-5","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T22:11:26Z","timestamp":1755727886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of glibenclamide pretreatment on outcomes in acute ischemic stroke patients with type 2 diabetes: a retrospective case-control study"],"prefix":"10.1038","volume":"15","author":[{"given":"Kaimin","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongxin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heling","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"6","key":"15764_CR1","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1111\/ijs.12579","volume":"10","author":"G Ntaios","year":"2015","unstructured":"Ntaios, G. et al. European stroke organisation (ESO) guidelines for the management of Tempe rature in patients with acute ischemic stroke. Stroke. 10 (6), 941\u2013949 (2015).","journal-title":"Stroke"},{"issue":"8","key":"15764_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1161\/CIRCULATIONAHA.116.025250","volume":"135","author":"W Wang","year":"2017","unstructured":"Wang, W. et al. Prevalence, incidence, and mortality of stroke in china: Results from a nationwide population-based survey of 480687 adults. Circulation. 135 (8), 759\u2013771 (2017).","journal-title":"Adults Circulation"},{"key":"15764_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.wneu.2016.11.006","volume":"98","author":"D Wang","year":"2017","unstructured":"Wang, D. et al. Patterns of stroke between university hospitals and nonuniversity hospitals in Mainland china: Prospective multicenter hospital-based registry study. World Neurosurg. 98, 258\u2013265 (2017).","journal-title":"World Neurosurg."},{"issue":"11","key":"15764_CR4","doi-asserted-by":"publisher","first-page":"e13849","DOI":"10.1111\/eci.13849","volume":"52","author":"M Nath","year":"2022","unstructured":"Nath, M. et al. Association of modifiable risk factors with ischaemic stroke subtypes in Asian versus Caucasian populations: A systematic review and meta-analysis. Eur. J. Clin. Invest. 52 (11), e13849 (2022).","journal-title":"Eur. J. Clin. Invest."},{"issue":"12","key":"15764_CR5","doi-asserted-by":"publisher","first-page":"e005610","DOI":"10.1161\/CIRCOUTCOMES.119.005610","volume":"12","author":"J Liu","year":"2019","unstructured":"Liu, J. et al. Trends in outcomes of patients with ischemic stroke treated between 2002 and 2016: Insights from a Chinese cohort. Circ. Cardiovasc. Qual. Outcomes. 12 (12), e005610 (2019).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"9882","key":"15764_CR6","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","volume":"381","author":"G Yang","year":"2013","unstructured":"Yang, G. et al. Rapid health transition in china, 1990\u20132010: Findings from the global burden of disease study 2010. Lancet. 381 (9882), 1987\u20132015 (2013).","journal-title":"Lancet"},{"issue":"6","key":"15764_CR7","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1136\/svn-2023-002998","volume":"8","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Chinese stroke association guidelines for clinical management of ischaemic cerebrovascular diseases: Executive summary and 2023 update. Stroke Vasc Neurol. 8 (6), e3 (2023).","journal-title":"Stroke Vasc Neurol."},{"issue":"1","key":"15764_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1567202619666220331160024","volume":"19","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. Analysis of prognostic risk factors for ischemic stroke in china: A multicentre retrospective clinical study; a national survey in China. Curr. Neurovasc Res. 19 (1), 117\u2013126 (2022).","journal-title":"Curr. Neurovasc Res."},{"key":"15764_CR9","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","volume":"375","author":"N Sarwar","year":"2010","unstructured":"Sarwar, N. et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 375, 2215\u20132222 (2010).","journal-title":"Lancet"},{"key":"15764_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/archneurol.2011.146","volume":"68","author":"A Callahan","year":"2011","unstructured":"Callahan, A. et al. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: Secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial. Arch. Neurol. 68, 1245\u20131251 (2011).","journal-title":"Arch. Neurol."},{"issue":"5","key":"15764_CR11","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1074\/jbc.M112.428219","volume":"288","author":"SK Woo","year":"2013","unstructured":"Woo, S. K. et al. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J. Biol. Chem. 288 (5), 3655\u20133667 (2013).","journal-title":"J. Biol. Chem."},{"key":"15764_CR12","doi-asserted-by":"publisher","first-page":"107845","DOI":"10.1016\/j.neuropharm.2019.107845","volume":"162","author":"X Wang","year":"2020","unstructured":"Wang, X. et al. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice. Neuropharmacology. 162, 107845 (2020).","journal-title":"Neuropharmacology"},{"issue":"6","key":"15764_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1161\/STROKEAHA.117.020365","volume":"49","author":"KN Sheth","year":"2018","unstructured":"Sheth, K. N. et al. Long-term outcomes in patients aged\u2009\u2264\u200970 years with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction:   An exploratory analysis. Stroke. 49 (6), 1457\u20131463 (2018).","journal-title":"Stroke"},{"issue":"7","key":"15764_CR14","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer, D. O. et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American heart association\/american stroke Association. Stroke. 52 (7), e364\u2013e467 (2021).","journal-title":"Stroke"},{"issue":"2","key":"15764_CR15","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1212\/WNL.0000000000207387","volume":"101","author":"J Fan","year":"2023","unstructured":"Fan, J. et al. Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990\u20132030. Neurology. 101 (2), e137\u2013e150 (2023).","journal-title":"Neurology"},{"issue":"25","key":"15764_CR16","first-page":"2429","volume":"379","author":"GBD 2016 Lifetime Risk of Stroke Collaborators","year":"2018","unstructured":"GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N. Engl. J. Med. 379 (25), 2429\u20132437 (2018).","journal-title":"J. Med."},{"issue":"8","key":"15764_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1177\/1747493019881353","volume":"14","author":"MP Lindsay","year":"2019","unstructured":"Lindsay, M. P. et al. World stroke organization (WSO): Global stroke fact sheet 2019. Int. J. Stroke. 14 (8), 806\u2013817 (2019).","journal-title":"Int. J. Stroke"},{"issue":"9","key":"15764_CR18","doi-asserted-by":"publisher","first-page":"e209323","DOI":"10.1212\/WNL.0000000000209323","volume":"102","author":"AM Southerland","year":"2024","unstructured":"Southerland, A. M. et al. Glucose control and risk of symptomatic intracerebral hemorrhage following thrombolysis for acute ischemic stroke: A SHINE trial analysis. Neurology. 102 (9), e209323 (2024).","journal-title":"Neurology"},{"issue":"47","key":"15764_CR19","doi-asserted-by":"publisher","first-page":"e36114","DOI":"10.1097\/MD.0000000000036114","volume":"102","author":"J Liu","year":"2023","unstructured":"Liu, J., Li, X. & Qu, J. Risk factors for acute ischemic stroke in patients with type 2 diabetes mellitus. Med. (Baltim). 102 (47), e36114 (2023).","journal-title":"Med. (Baltim)."},{"issue":"13","key":"15764_CR20","doi-asserted-by":"publisher","first-page":"e1732","DOI":"10.1212\/WNL.0000000000011555","volume":"96","author":"MK Georgakis","year":"2021","unstructured":"Georgakis, M. K. et al. Diabetes mellitus, glycemic traits, and cerebrovascular disease: A Mendelian randomization study. Neurology. 96 (13), e1732\u2013e1742 (2021).","journal-title":"Neurology"},{"issue":"2\u20134","key":"15764_CR21","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.3909\/ricm0671","volume":"14","author":"DS Bell","year":"2013","unstructured":"Bell, D. S., Patil, H. R. & O\u2019Keefe, J. H. Divergent effects of various diabetes drugs on cardiovascular prognosis. Rev. Cardiovasc. Med. 14 (2\u20134), e107\u2013e122 (2013).","journal-title":"Rev. Cardiovasc. Med."},{"issue":"4","key":"15764_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/japtr.JAPTR_317_18","volume":"9","author":"NR Hussien","year":"2018","unstructured":"Hussien, N. R. et al. Sulfonylurea and neuroprotection: The bright side of the moon. J. Adv. Pharm. Technol. Res. 9 (4), 120\u2013123 (2018).","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"3","key":"15764_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/STROKEAHA.109.572644","volume":"41","author":"JM Simard","year":"2010","unstructured":"Simard, J. M. et al. Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke. Stroke. 41 (3), 531\u2013537 (2010).","journal-title":"Stroke"},{"issue":"8","key":"15764_CR24","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1172\/JCI32041","volume":"117","author":"JM Simard","year":"2007","unstructured":"Simard, J. M. et al. Endothelial sulfonylurea receptor 1-regulated NC Ca-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury. J. Clin. Invest. 117 (8), 2105\u20132113 (2007).","journal-title":"J. Clin. Invest."},{"key":"15764_CR25","first-page":"2023","volume":"8","author":"X Feng","year":"2024","unstructured":"Feng, X. et al. Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: A randomised, double-blind, placebo-controlled clinical trial. Stroke Vasc Neurol. 8, 2023 (2024).","journal-title":"Stroke Vasc Neurol."},{"issue":"7","key":"15764_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1089\/neu.2018.5986","volume":"36","author":"V Gerzanich","year":"2019","unstructured":"Gerzanich, V. et al. Sulfonylurea receptor 1, transient receptor potential cation channel subfamily M member 4, and KIR6.2:Role in hemorrhagic progression of contusion. J. Neurotrauma. 36 (7), 1060\u20131079 (2019).","journal-title":"J. Neurotrauma"},{"issue":"3","key":"15764_CR27","doi-asserted-by":"publisher","first-page":"105595","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105595","volume":"30","author":"T Igarashi","year":"2021","unstructured":"Igarashi, T. et al. Continuous Glibenclamide prevents hemorrhagic transformation in a rodent model of severe ischemia-reperfusion. J. Stroke Cerebrovasc. Dis. 30 (3), 105595 (2021).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"3","key":"15764_CR28","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/ane.13134","volume":"140","author":"K Huang","year":"2019","unstructured":"Huang, K. et al. Exploratory analysis of oral Glibenclamide in acute ischemic stroke. Acta Neurol. Scand. 140 (3), 212\u2013218 (2019).","journal-title":"Acta Neurol. Scand."},{"issue":"5","key":"15764_CR29","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.23680","volume":"72","author":"H Kunte","year":"2012","unstructured":"Kunte, H. et al. Hemorrhagic transformation of ischemic stroke in diabetics on sulfonylureas. Ann. Neurol. 72 (5), 799\u2013806 (2012).","journal-title":"Ann. Neurol."},{"key":"15764_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/NEN.0000000000000223","volume":"74","author":"RI Mehta","year":"2015","unstructured":"Mehta, R. I. et al. Sur-trpm4 cation channel expression in human cerebral infarcts. J. Neuropathol. Exp. Neurol. 74, 835\u2013849 (2015).","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"15764_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/jcbfm.2012.166","volume":"33","author":"FJ Ortega","year":"2013","unstructured":"Ortega, F. J. et al. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 33 (3), 356\u2013364 (2013).","journal-title":"J. Cereb. Blood Flow. Metab."}],"updated-by":[{"DOI":"10.1038\/s41598-025-29202-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15764-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15764-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T10:12:52Z","timestamp":1764065572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15764-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15764"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15764-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"24 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-29202-z","URL":"https:\/\/doi.org\/10.1038\/s41598-025-29202-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30666"}}